<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04454268</url>
  </required_header>
  <id_info>
    <org_study_id>Intracranial Hydatid Cyst</org_study_id>
    <nct_id>NCT04454268</nct_id>
  </id_info>
  <brief_title>Intracranial Hydatid Cyst</brief_title>
  <official_title>Intracranial Hydatid Cyst: Series of 8 Cases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Central nervous system (CNS) hydatid cysts is a rare presentation of hydatid cyst, although
      may be the cause of intracranial space-occupying lesions in 4% in endemic countries. It
      affects mostly children. The diagnosis of CNS hydatid is still problematic in spite of the
      advancements in imaging techniques (CT or MRI). Extirpation of the intact cyst is the
      treatment of choice, resulting in most cases to a complete recovery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hydatid disease is a parasitic induced disease caused by either Echinococcus granulosus or
      Echinococcus multilocularis during the larval stage of these tapeworms. Hydatid cysts are
      endemic in many countries, such as Latin America (Argentina, Brazil, Chile, Peru, and
      Uruguay); followed by Europe (France, Italy, and Greece), the Middle East (Turkey, Lebanon,
      Syria, and Jordan), Southeast Asia (China, Iran, and India) and Africa (Tunisia and less
      commonly, Egypt)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2010</start_date>
  <completion_date type="Actual">January 10, 2018</completion_date>
  <primary_completion_date type="Actual">January 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of patients who haven total removal of intracranial cyst</measure>
    <time_frame>7 years</time_frame>
    <description>degree of consciousness incomplete extirpation without removal without neurological deficit 0 space</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Intracranial Neoplasm</condition>
  <arm_group>
    <arm_group_label>hydatid cyst</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cyst extirpation</intervention_name>
    <description>complete removal of the cyst without rupture</description>
    <arm_group_label>hydatid cyst</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  intracranial hydatid cyst

        Exclusion Criteria:

          -  Arachnoid cysts

          -  conservative treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 27, 2020</study_first_submitted>
  <study_first_submitted_qc>June 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2020</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>ahmed salaheldin mohammed saro</investigator_full_name>
    <investigator_title>Assistant professor of neurosurgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Echinococcosis</mesh_term>
    <mesh_term>Brain Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

